AdvtAdvtJoin the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Download the ETPharma App and get the Realtime updates and Save your favourite articles. Sanofi board member Olivier Charmeil will serve as acting CEO during the transition.Garijo previously worked for 15 years at Sanofi and was a board member at French ​cosmetics giant L'Oreal. (Reporting by Alessandro Parodi in Gdansk and Bhanvi Satija in London; Editing by Matt Scuffham, Adam Jourdan and Joe Bavier)>

Source: Economic Times February 12, 2026 15:49 UTC